Don't throw out the baby with the bathwater: On optimizing cure and reducing toxicity in Hodgkin's lymphoma

被引:26
作者
Yahalom, J [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1200/JCO.2005.04.4396
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:544 / 548
页数:5
相关论文
共 39 条
[21]   Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease [J].
Loeffler, M ;
Diehl, V ;
Pfreundschuh, M ;
Ruhl, U ;
Hasenclever, D ;
NistersBackes, H ;
Sieber, M ;
Tesch, H ;
Franklin, J ;
Geilen, W ;
Bartels, H ;
Cartoni, C ;
Dolken, G ;
Enzian, J ;
Fuchs, R ;
Gassmann, W ;
Gerhartz, H ;
HagenAukamp, U ;
Hiller, E ;
Hinkelbein, H ;
Hinterberger, W ;
Kirchner, H ;
Koch, P ;
Kruger, B ;
Kurten, H ;
Kutzner, K ;
Loos, U ;
Mende, W ;
Muller, H ;
Oertel, W ;
Petsch, S ;
Pfab, R ;
Pfluger, H ;
Rohloff, R ;
Sauer, R ;
Schalk, K ;
Schick, HD ;
Schoppe, W ;
Szepesi, S ;
Teichmann, J ;
Worst, P ;
Fischer, R ;
Georgii, A ;
Hubner, K ;
Schwarze, EW .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2275-2287
[22]   Radiation therapy in Hodgkin disease: Why risk a Pyrrhic victory? [J].
Longo, DL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (19) :1394-1395
[23]   Hodgkin disease: the sword of Damocles resheathed [J].
Longo, DL .
BLOOD, 2004, 104 (12) :3418-3418
[24]   Radiation therapy in the treatment of Hodgkin's disease - Do you see what I see? [J].
Longo, DL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :928-929
[25]   Lung cancer after treatment for Hodgkin's lymphoma: a systematic review [J].
Lorigan, P ;
Radford, J ;
Howell, A ;
Thatcher, N .
LANCET ONCOLOGY, 2005, 6 (10) :773-779
[26]   Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma [J].
Martin, WG ;
Ristow, KM ;
Habermann, TM ;
Colgan, JP ;
Witzig, TE ;
Ansell, SM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7614-7620
[27]   Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group [J].
Meyer, RM ;
Gospodarowicz, MK ;
Connors, JM ;
Pearcey, RG ;
Bezjak, A ;
Wells, WA ;
Burns, BE ;
Winter, JN ;
Horning, SJ ;
Dar, AR ;
Djurfeldt, MS ;
Ding, K ;
Shepherd, LE .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) :4634-4642
[28]   Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy [J].
Nachman, JB ;
Sposto, R ;
Herzog, P ;
Gilchrist, GS ;
Wolden, SL ;
Thomson, J ;
Kadin, ME ;
Pattengale, P ;
Davis, PC ;
Hutchinson, RJ ;
White, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3765-3771
[29]  
*NCCN, 2006, NCCN GUID HODGK DIS
[30]   Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger [J].
Ng, AK ;
Bernardo, MP ;
Weller, E ;
Backstrand, KH ;
Silver, B ;
Marcus, KC ;
Tarbell, NJ ;
Friedberg, J ;
Canellos, GP ;
Mauch, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2101-2108